| Title |
Monoamine oxidase B inhibitors for early Parkinson's disease
|
|---|---|
| Published in |
Cochrane database of systematic reviews, July 2005
|
| DOI | 10.1002/14651858.cd004898.pub2 |
| Pubmed ID | |
| Authors |
Kristian Turnbull, Robert Caslake, Angus Macleod, Natalie Ives, Rebecca Stowe, Carl Counsell |
| Abstract |
It has been postulated that monoamine oxidase B (MAO-B) inhibitors alter disease progression in Parkinson's disease (PD). Clinical trials have produced conflicting results. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 161 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | <1% |
| Colombia | 1 | <1% |
| France | 1 | <1% |
| Unknown | 158 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 22 | 14% |
| Student > Master | 21 | 13% |
| Student > Ph. D. Student | 15 | 9% |
| Other | 13 | 8% |
| Researcher | 13 | 8% |
| Other | 42 | 26% |
| Unknown | 35 | 22% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 50 | 31% |
| Neuroscience | 16 | 10% |
| Nursing and Health Professions | 10 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 6% |
| Agricultural and Biological Sciences | 8 | 5% |
| Other | 25 | 16% |
| Unknown | 42 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 March 2016.
All research outputs
#16,781,609
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#10,370
of 11,499 outputs
Outputs of similar age
#61,600
of 69,215 outputs
Outputs of similar age from Cochrane database of systematic reviews
#34
of 39 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 69,215 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.